Tuomas Waltimo

Tuomas Waltimo

Auto-generated profile, based on publicly available information

Tuomas Waltimo

Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Faculty of Medicine, University of Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
BZBarbara Zeller
Barbara Zeller
SSSimone Stöckli
Simone Stöckli
LZLucia K. Zaugg
Lucia K. Zaugg
MAMonika Astasov-Frauenhoffer
Monika Astasov-Frauenhoffer
IHIrmgard Hauser‐Gerspach
Irmgard Hauser‐Gerspach
NZNicola Ursula Zitzmann
Nicola Ursula Zitzmann

27 October 2023 in Oral Diseases
Verified
Journal Article
Closed access
JTJulie Toby
Julie Toby
BJBetsy Joseph
Betsy Joseph
TSTimo Sorsa
Timo Sorsa
MMMatti Mauramo
Matti Mauramo
Sukumaran AnilSukumaran Anil
Sukumaran Anil
TWTuomas Waltimo
Tuomas Waltimo

25 July 2023 in Clinical Oral Implants Research
Verified
Journal Article
Open access
DMDonat Meier
Donat Meier
MAMonika Astasov-Frauenhoffer
Monika Astasov-Frauenhoffer
TWTuomas Waltimo
Tuomas Waltimo
LZLucia K. Zaugg
Lucia K. Zaugg
RNRohr Nadja
Rohr Nadja
NZNicola Ursula Zitzmann
Nicola Ursula Zitzmann
Objectives: Composition of implant material and its surface structure is decisive for oral biofilm accumulation. This study investigated biofilm formation on eight different materials.Materials and Methods: Eighteen healthy subjects wore intraoral splints fitted with two sets of eight materials for 24 h: zirconia [ZrO2]; silver‐gold–palladium [AgAuPd]; titanium zirconium [TiZr]; Pagalinor [PA]; hydroxyapatite [HA]; silver‐platinum [AgPt]; titanium aluminum niobium [TAN]; titanium grade4 [TiGr4]. Total biomass was stained by safranin to assess plaque accumulation while conventional culturing (CFU) was conducted to investigate viable parts of the biofilm. Cell viability of human gingival fibroblasts (HGF‐1) was assessed in vitro. Statistical evaluation was performed with linear mixed‐effects models to compare materials (geometric mean ratios, 95% CI), with the level of significance set at ɑ = .05.Results: Less biofilm mass and CFU were found on noble metal alloys (AgPt, AgAuPd, and PA). Compared to AgPt, PA had 2.7‐times higher biofilm mass value, AgAuPd was 3.9‐times, TiGr4 was 4.1‐times, TiZr was 5.9‐times, TAN was 7.7‐times, HA was 7.8‐times, and ZrO2 was 9.1‐times higher (each p < .001). Similarly, CFU data were significantly lower on AgPt, AgAuPd had 4.1‐times higher CFU values, PA was 8.9‐times, TiGr4 was 11.2‐times, HA was 12.5‐times, TiZr was 13.3‐times, TAN was 16.9‐times, and ZrO2 was 18.5‐times higher (each p < .001). HGF‐1 viability varied between 47 ± 24.5% (HA) and 94.4 ± 24.6% (PA).Conclusion: Noble alloys are considered as beneficial materials for the transmucosal part of oral implants, as less biofilm mass, lower bacterial counts, and greater cell viability were detected than on titanium‐ or zirconia‐based materials.

22 April 2025 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Verified
Journal Article
Open access
BJBetsy Joseph
Betsy Joseph
MMMatti Mauramo
Matti Mauramo
TSTimo Sorsa
Timo Sorsa
Sukumaran AnilSukumaran Anil
Sukumaran Anil
TWTuomas Waltimo
Tuomas Waltimo
This systematic review aimed to evaluate the efficacy of light-emitting diode (LED) therapy in reducing oral mucositis (OM) severity, pain, and healing time in cancer patients and compare it to standard care or sham light. A comprehensive search of major databases was conducted using relevant MeSH terms and keywords. Two authors independently screened studies meeting the eligibility criteria. The Cochrane Risk-of-Bias tool for randomized controlled trials (RoB-2) and the Risk of Bias in Non-Randomized Studies - of Interventions (ROBINS-I) were used to assess the methodological quality of included studies. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. The review included five studies (256 participants). Four studies reported significant improvements in OM severity and pain with LED therapy while only one study suggested improved healing time. The risk of bias was moderate among the included studies. Due to heterogeneous data, a meta-analysis could not be performed. The GRADE assessment indicated low certainty of evidence, highlighting the need for further clinical research. LED therapy may effectively manage cancer therapy-induced OM by reducing patient-reported pain and OM duration. However, the low certainty of evidence warrants more well-designed, longitudinal studies with larger sample sizes to confirm these findings and establish optimal treatment protocols.